Back to Journals » Cancer Management and Research » Volume 13

LINC00504 Promotes the Malignant Biological Behavior of Breast Cancer Cells by Upregulating HMGB3 via Decoying MicroRNA-876-3p [Expression of Concern]

Authors Yu H, Dong L, Wang H, Zhang Y, Wang Z, Wang C, Xia H, Bao H

Received 15 October 2021

Accepted for publication 15 October 2021

Published 20 October 2021 Volume 2021:13 Pages 7961—7962

DOI https://doi.org/10.2147/CMAR.S344583

Download Article [PDF] 

Yu H, Dong L, Wang H, et al. Cancer Manag Res. 2021;13:1803–1815.

The Editor and Publisher of Cancer Management and Research wish to publish an Expression of Concern for the published article. Following publication, concerns were raised about the scientific integrity of the articles content. We reached out to the authors requesting they supply information that would confirm the integrity of the data. The authors provided several files in response to our queries but they did not satisfy our requirements to confirm the authenticity of some types of data. In addition, there were unexplained similarities between some of the figures presented in this article, and figures presented in articles by different authors groups. As yet, the authors have not provided a satisfactory explanation for this.

Therefore, as we continue to work through the issues raised, we advise readers to interpret the information presented in the article with due caution.

The authors have been notified about this Expression of Concern.

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]